Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- CheckyesterdayChange DetectedFooter/navigation updates include a new 'Revision: v3.3.3' label and removal of the 'HHS Vulnerability Disclosure' link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.3.2 to the version history and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the banner notice about government funding status and NIH operations from the page.SummaryDifference0.6%

- Check51 days agoChange DetectedThe old and new screenshots show the same Study Record Versions data and overall page content; only cosmetic UI adjustments (layout, borders, colors) are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference11%

- Check87 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.